09/02/2026
A series of unexpected opportunities led Michael Babich from to biotech entrepreneurship, where he now advances cancer research and treatment. His college path included a spot on the football team, involvement in ROTC and ultimately, a degree in biology and chemistry. These days, he’s combined his background in military, academia and business as the co-founder and CEO of LabyRx, a medical company developing a vaccine treatment for cancer. Below, you can read more about his career and the support he experienced while at EKU! 🧪👨🔬
🔗: https://www.eku.edu/news/a-chain-reaction/